Inmagene

Public

San Diego, CaliforniaBiotechhttps://www.inmagenebio.com

Last Round

Private Placement

Jul 25, 2025

Est. Valuation

$347.22M

Total Funding Raised

$216M

Company Overview

Inmagene is a biotechnology company dedicated to developing innovative therapeutics for immunological and inflammatory diseases.

Sector

Biotech

AI Layer

Non-AI

Keywords

non-depleting anti-OX40 monoclonal antibodyimmunological and inflammatory disease therapeuticsatopic dermatitis biologicsIL-17A inhibitor for psoriatic arthritisextended half-life monoclonal antibodyalopecia areata therapeuticsnon-covalent reversible BTK inhibitoranti-IL-36R mAb for generalized pustular psoriasisclinical-stage immunology drug developmentbiotech drug in-licensing and co-developmentclinical-stage biotechnology company

Inmagene Comps

Public and private peers based on sector, stage, and business model.

Inmagene comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Inmagene Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Private Placement	Jul 25, 2025
Series C	Jun 1, 2021
Series B	Nov 9, 2020
Series A	Feb 1, 2020

View all Funding Rounds

Inmagene Investors

Notable investors and investment history

Inmagene investors
Investor	Rounds
HighLight Capital	Series C
SCVC	Series B
Omega Funds	Private Placement
Highlight Capital	Series C
Jiangsu Honghui Equity Investment Management	Series C
Triwise Capital	Series C
Blue Owl Capital	Private Placement

View all Investors

Inmagene Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Inmagene Filings

SEC and related filings with document metadata.

Firmographic Details

HeadquartersSan Diego, California

Year Founded2019

Last FundingJul 25, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.